Salveen Richter Score: 13
Analyst at
Goldman Sachs
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-7.6%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
31%
9 W / 20 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
21%
3 W / 11 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 14 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 14 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
35%
8 W / 15 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
36%
8 W / 14 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
14%
1 W / 6 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 |
uniQure N.V.
QURE
|
SELL |
$46.00
Est. +4%
|
$48.16 | $45.77 (Low) |
Bullseye Hit (±1%)
|
$46.29
+3.9%
|
| Apr 28, 2026 |
Relay Therapeutics Inc
RLAY
|
BUY |
$22.00
Est. +47%
|
$14.95 | $17.47 |
Pending
|
$15.88
+6.2%
|
| Jan 08, 2026 |
Biogen Inc
BIIB
|
BUY |
$225.00
Est. +20%
|
$186.91 | $205.97 |
Pending
|
$196.58
+5.2%
|
| Oct 30, 2025 |
Arcus Biosciences Inc
RCUS
|
SELL |
$16.00
Est. +22%
|
$20.64 | $18.32 (Low) |
Pending
|
$24.31
-17.8%
|
| Oct 30, 2024 |
Biogen Inc
BIIB
|
BUY |
$290.00
Est. +60%
|
$181.18 | $185.00 |
Miss
|
$196.58
+8.5%
|
| Oct 21, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$598.00
Est. +24%
|
$483.00 | $519.88 |
Miss
|
$451.63
-6.5%
|
| Oct 16, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$369.00
Est. +14%
|
$325.09 | $335.88 |
Miss
|
$337.60
+3.8%
|
| Sep 24, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,292.00
Est. +18%
|
$1,091.98 | $1,080.00 |
Miss
|
$609.94
-44.1%
|
| Sep 16, 2024 |
Incyte Corp.
INCY
|
SELL |
$60.00
Est. +6%
|
$63.56 | $53.56 (Low) |
Target Met
|
$98.22
-54.5%
|
| Sep 12, 2024 |
Gilead Sciences, Inc.
GILD
|
SELL |
$71.00
Est. +14%
|
$82.85 | $81.57 (Low) |
Miss
|
$123.76
-49.4%
|
| Sep 03, 2024 |
Denali Therapeutics Inc
DNLI
|
BUY |
$46.00
Est. +83%
|
$25.12 | $33.32 |
Miss
|
$23.31
-7.2%
|
| Aug 16, 2024 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$370.00
Est. +41%
|
$262.70 | $449.52 |
Target Met
|
$278.09
+5.9%
|
| Jul 26, 2024 |
Biogen Inc
BIIB
|
BUY |
$342.00
Est. +62%
|
$211.17 | $219.44 |
Miss
|
$196.58
-6.9%
|
| Jul 22, 2024 |
Ionis Pharmaceuticals Inc
IONS
|
SELL |
$33.00
Est. +35%
|
$50.61 | $23.95 (Low) |
Target Met
|
$74.12
-46.5%
|
| Jun 06, 2024 |
2seventy bio Inc
TSVT
|
SELL |
$2.00
Est. +56%
|
$4.56 | $2.29 (Low) |
Miss
|
$5.00
-9.6%
|
| Jun 06, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$67.00
Est. +62%
|
$41.45 | $60.37 |
Miss
|
$27.44
-33.8%
|
| Apr 17, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$28.00
Est. +131%
|
$12.11 | $13.46 |
Miss
|
$8.68
-28.3%
|
| Dec 06, 2021 |
AMGEN Inc.
AMGN
|
BUY |
$258.00
Est. +25%
|
$207.02 | - | - |
$337.60
+63.1%
|
| Dec 06, 2021 |
Gilead Sciences, Inc.
GILD
|
BUY |
$80.00
Est. +18%
|
$67.94 | - | - |
$123.76
+82.2%
|
| Dec 06, 2021 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$824.00
Est. +32%
|
$625.00 | - | - |
$609.94
-2.4%
|
| Dec 06, 2021 |
Biogen Inc
BIIB
|
BUY |
$271.00
Est. +21%
|
$224.11 | - | - |
$196.58
-12.3%
|
| Nov 24, 2021 |
Incyte Corp.
INCY
|
BUY |
$136.00
Est. +104%
|
$66.74 | - | - |
$98.22
+47.2%
|
| Nov 22, 2021 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$273.00
Est. +46%
|
$187.01 | - | - |
$278.09
+48.7%
|
| Nov 08, 2021 |
Bluebird bio Inc
BLUE
|
SELL |
$10.00
Est. +7%
|
$10.70 | $57.30 (Low) |
Miss
|
$4.97
+53.6%
|
| Sep 21, 2021 |
Seagen Inc
SGEN
|
BUY |
$222.00
Est. +35%
|
$165.01 | - | - |
$228.74
+38.6%
|
| Aug 20, 2021 |
Intercept Pharmaceuticals Inc
ICPT
|
SELL |
$10.00
Est. +23%
|
$12.99 | - | - |
$19.00
-46.3%
|
| Aug 06, 2021 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$252.00
Est. +51%
|
$167.31 | - | - |
$15.67
-90.6%
|
| Aug 05, 2021 |
Denali Therapeutics Inc
DNLI
|
BUY |
$112.00
Est. +112%
|
$52.93 | - | - |
$23.31
-56.0%
|
| Jul 29, 2021 |
Blueprint Medicines Corp
BPMC
|
BUY |
$147.00
Est. +73%
|
$84.74 | - | - |
$129.46
+52.8%
|
| May 10, 2021 |
Amicus Therapeutics Inc
FOLD
|
BUY |
$14.00
Est. +49%
|
$9.39 | - | - |
$14.49
+54.3%
|
uniQure N.V.
QURE
Jun 18, 2026
Signal & Target
SELL
$46.00
Start Price
$48.16
Best Price (1Y)
$45.77
Current Price
$46.29
Return
+3.9%
Relay Therapeutics Inc
RLAY
Apr 28, 2026
Signal & Target
BUY
$22.00
Start Price
$14.95
Best Price (1Y)
$17.47
Current Price
$15.88
Return
+6.2%
Biogen Inc
BIIB
Jan 08, 2026
Signal & Target
BUY
$225.00
Start Price
$186.91
Best Price (1Y)
$205.97
Current Price
$196.58
Return
+5.2%
Arcus Biosciences Inc
RCUS
Oct 30, 2025
Signal & Target
SELL
$16.00
Start Price
$20.64
Best Price (1Y)
$18.32
Current Price
$24.31
Return
-17.8%
Biogen Inc
BIIB
Oct 30, 2024
Signal & Target
BUY
$290.00
Start Price
$181.18
Best Price (1Y)
$185.00
Current Price
$196.58
Return
+8.5%
Vertex Pharmaceuticals, Inc.
VRTX
Oct 21, 2024
Signal & Target
BUY
$598.00
Start Price
$483.00
Best Price (1Y)
$519.88
Current Price
$451.63
Return
-6.5%
AMGEN Inc.
AMGN
Oct 16, 2024
Signal & Target
BUY
$369.00
Start Price
$325.09
Best Price (1Y)
$335.88
Current Price
$337.60
Return
+3.8%
Regeneron Pharmaceuticals, Inc.
REGN
Sep 24, 2024
Signal & Target
BUY
$1,292.00
Start Price
$1,091.98
Best Price (1Y)
$1,080.00
Current Price
$609.94
Return
-44.1%
Incyte Corp.
INCY
Sep 16, 2024
Signal & Target
SELL
$60.00
Start Price
$63.56
Best Price (1Y)
$53.56
Current Price
$98.22
Return
-54.5%
Gilead Sciences, Inc.
GILD
Sep 12, 2024
Signal & Target
SELL
$71.00
Start Price
$82.85
Best Price (1Y)
$81.57
Current Price
$123.76
Return
-49.4%
Denali Therapeutics Inc
DNLI
Sep 03, 2024
Signal & Target
BUY
$46.00
Start Price
$25.12
Best Price (1Y)
$33.32
Current Price
$23.31
Return
-7.2%
Alnylam Pharmaceuticals Inc
ALNY
Aug 16, 2024
Signal & Target
BUY
$370.00
Start Price
$262.70
Best Price (1Y)
$449.52
Current Price
$278.09
Return
+5.9%
Biogen Inc
BIIB
Jul 26, 2024
Signal & Target
BUY
$342.00
Start Price
$211.17
Best Price (1Y)
$219.44
Current Price
$196.58
Return
-6.9%
Ionis Pharmaceuticals Inc
IONS
Jul 22, 2024
Signal & Target
SELL
$33.00
Start Price
$50.61
Best Price (1Y)
$23.95
Current Price
$74.12
Return
-46.5%
2seventy bio Inc
TSVT
Jun 06, 2024
Signal & Target
SELL
$2.00
Start Price
$4.56
Best Price (1Y)
$2.29
Current Price
$5.00
Return
-9.6%
Ultragenyx Pharmaceutical Inc.
RARE
Jun 06, 2024
Signal & Target
BUY
$67.00
Start Price
$41.45
Best Price (1Y)
$60.37
Current Price
$27.44
Return
-33.8%
Sage Therapeutics Inc
SAGE
Apr 17, 2024
Signal & Target
BUY
$28.00
Start Price
$12.11
Best Price (1Y)
$13.46
Current Price
$8.68
Return
-28.3%
AMGEN Inc.
AMGN
Dec 06, 2021
Signal & Target
BUY
$258.00
Start Price
$207.02
Best Price (1Y)
-
Current Price
$337.60
Return
+63.1%
Gilead Sciences, Inc.
GILD
Dec 06, 2021
Signal & Target
BUY
$80.00
Start Price
$67.94
Best Price (1Y)
-
Current Price
$123.76
Return
+82.2%
Regeneron Pharmaceuticals, Inc.
REGN
Dec 06, 2021
Signal & Target
BUY
$824.00
Start Price
$625.00
Best Price (1Y)
-
Current Price
$609.94
Return
-2.4%
Biogen Inc
BIIB
Dec 06, 2021
Signal & Target
BUY
$271.00
Start Price
$224.11
Best Price (1Y)
-
Current Price
$196.58
Return
-12.3%
Incyte Corp.
INCY
Nov 24, 2021
Signal & Target
BUY
$136.00
Start Price
$66.74
Best Price (1Y)
-
Current Price
$98.22
Return
+47.2%
Alnylam Pharmaceuticals Inc
ALNY
Nov 22, 2021
Signal & Target
BUY
$273.00
Start Price
$187.01
Best Price (1Y)
-
Current Price
$278.09
Return
+48.7%
Bluebird bio Inc
BLUE
Nov 08, 2021
Signal & Target
SELL
$10.00
Start Price
$10.70
Best Price (1Y)
$57.30
Current Price
$4.97
Return
+53.6%
Seagen Inc
SGEN
Sep 21, 2021
Signal & Target
BUY
$222.00
Start Price
$165.01
Best Price (1Y)
-
Current Price
$228.74
Return
+38.6%
Intercept Pharmaceuticals Inc
ICPT
Aug 20, 2021
Signal & Target
SELL
$10.00
Start Price
$12.99
Best Price (1Y)
-
Current Price
$19.00
Return
-46.3%
Intellia Therapeutics Inc
NTLA
Aug 06, 2021
Signal & Target
BUY
$252.00
Start Price
$167.31
Best Price (1Y)
-
Current Price
$15.67
Return
-90.6%
Denali Therapeutics Inc
DNLI
Aug 05, 2021
Signal & Target
BUY
$112.00
Start Price
$52.93
Best Price (1Y)
-
Current Price
$23.31
Return
-56.0%
Blueprint Medicines Corp
BPMC
Jul 29, 2021
Signal & Target
BUY
$147.00
Start Price
$84.74
Best Price (1Y)
-
Current Price
$129.46
Return
+52.8%
Amicus Therapeutics Inc
FOLD
May 10, 2021
Signal & Target
BUY
$14.00
Start Price
$9.39
Best Price (1Y)
-
Current Price
$14.49
Return
+54.3%